SCHEMBL4362996

SCHEMBL4362996

COc1ccccc1C(NCCO)(c1ccccc1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
HSD17B10 Q99714 1/20 0.42
KIF11 P52732 1/20 0.42
TSHR P16473 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
KCNN4 O15554 2/20 0.41
KDM4E B2RXH2 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
HTT P42858 2/20 0.39
USP2 O75604 1/20 0.39
RAD52 P43351 1/20 0.39
NR3C2 P08235 1/20 0.39
GBA1 P04062 1/20 0.39
KCNA5 P22460 1/20 0.38
GAA P10253 3/20 0.38
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA4 P22748 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6306727 0.93 ALDH1A1 (0.47) ALDH1A1HSD17B10KIF11TSHRL3MBTL1
SCHEMBL2489143 0.92 ALDH1A1 (0.45) ALDH1A1HSD17B10TSHRL3MBTL1KDM4E
SCHEMBL18705415 0.90 ALDH1A1 (0.44) ALDH1A1HSD17B10TSHRKDM4EMEN1
SCHEMBL2490295 0.84 KCNN4 (0.61) ALDH1A1KIF11L3MBTL1KCNN4MEN1
SCHEMBL6306730 0.83 KIF11 (0.36) ALDH1A1KIF11L3MBTL1KCNN4MEN1
SCHEMBL2490248 0.83 ALDH1A1 (0.43) ALDH1A1HSD17B10TSHRKDM4ERAD52
SCHEMBL4367354 0.81 KMT2A (0.38) ALDH1A1KCNN4KDM4EMEN1KMT2A
SCHEMBL4367360 0.81 KMT2A (0.38) ALDH1A1KCNN4KDM4EMEN1KMT2A
SCHEMBL15841351 0.79 ACHE (0.41) ALDH1A1HSD17B10
SCHEMBL4363002 0.78 KIF11 (0.49) ALDH1A1KIF11L3MBTL1KCNN4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2749566-B1 SOLID-PHASE CARRIER FOR AMINATED OLIGONUCLEOTIDE AIST (JP) 2018-05-09 EP disclosed
US-9428809-B2 Solid-phase carrier for aminated oligonucleotide NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2016-08-30 US disclosed
US-20140187724-A1 SOLID-PHASE CARRIER FOR AMINATED OLIGONUCLEOTIDE NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2014-07-03 US disclosed
EP-2749566-A1 SOLID-PHASE CARRIER FOR AMINATED OLIGONUCLEOTIDE National Institute of Advanced Industrial Science And Technology (JP) 2014-07-02 EP disclosed
EP-1908829-B1 OLIGONUCLEOTIDE PROBE NAT INST OF ADVANCED IND SCIEN (JP) 2014-01-08 EP disclosed
US-7491857-B2 Oligonucleotide probe NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2009-02-17 US disclosed
US-20080227968-A1 Oligonucleotide Probe NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2008-09-18 US disclosed
EP-1908829-A1 OLIGONUCLEOTIDE PROBE National Institute of Advanced Industrial Science and Technology (JP) 2008-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080227968-A1 Oligonucleotide Probe APEX1, RNGTT, RNASEH1 ALDH1A1 181/4885HSD17B10 1679/4885KIF11 3783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.